Abstract:Background: Characterizing the multiorgan manifestations and outcomes of patients hospitalized with COVID-19 will inform resource requirements to address the long-term burden of this disease. We conducted a descriptive analysis using prospectively collected data to describe the clinical characteristics and spectrum of organ dysfunction, and in-hospital and longer-term clinical outcomes of patients hospitalized with COVID-19 during the first wave of the pandemic at a Canadian centre. Methods: We conducted a prospective case series involving adult patients (aged ≥ 18 yr) with COVID-19 admitted to 1 of 2 hospitals in London, Ontario, from Mar. 17 to June 18, 2020, during the first wave of the pandemic. We recorded patients' baseline characteristics, physiologic parameters, measures of organ function and therapies administered during hospitalization among patients in the intensive care unit (ICU) and in non-ICU settings, and compared the characteristics of hospital survivors and nonsurvivors. Finally, we recorded follow-up thoracic computed tomography (CT) and echocardiographic findings after hospital discharge. Results: We enrolled 100 consecutive patients (47 women) hospitalized with COVID-19, including 32 patients who received ICU care and 68 who received treatment in non-ICU settings. Respiratory sequelae were common: 23.0% received high-flow oxygen by nasal cannula, 9.0% received noninvasive ventilation, 24.0% received invasive mechanical ventilation and 2.0% received venovenous extracorporeal membrane oxygenation. Overall, 9.0% of patients had cerebrovascular events (3.0% ischemic stroke, 6.0% intracranial hemorrhage), and 6.0% had pulmonary embolism. After discharge, 11 of 19 patients had persistent abnormalities on CT thorax, and 6 of 15 had persistent cardiac dysfunction on echocardiography. Interpretation: This study provides further evidence that COVID-19 is a multisystem disease involving neurologic, cardiac and thrombotic dysfunction, without evidence of hepatic dysfunction. Patients have persistent organ dysfunction after hospital discharge, underscoring the need for research on long-term outcomes of COVID-19 survivors.

Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations

The Mechanism of Multiple Organ Dysfunction Syndrome in Patients with COVID‐19

The mechanism of multiple organ dysfunction syndrome in patients with COVID-19

Is COVID-19 Infection a Multiorganic Disease? Focus on Extrapulmonary Involvement of SARS-CoV-2

Beyond the lung involvement in COVID-19 patients

Pulmonary and Extra-Pulmonary Clinical Manifestations of COVID-19

Comprehensive Insights Into the Multi-faceted Manifestations of COVID-19: A Narrative Review

COVID-19: Current Understanding of Pathophysiology

COVID-19: a multi-organ perspective

Non-pulmonary involvement in COVID-19: A systemic disease rather than a pure respiratory infection

COVID-19 and multiorgan failure: A narrative review on potential mechanisms

Organ-specific manifestations of COVID-19 infection

COVID-19 Mechanisms in the Human Body—What We Know So Far

Pulmonary and Systemic Pathology in COVID-19—Holistic Pathological Analyses

Unraveling the mystery of Covid-19 cytokine storm: From skin to organ systems

COVID-19 Pathology on Various Organs and Regenerative Medicine and Stem Cell-Based Interventions

Multi-organ microphysiological system: A new paradigm for COVID-19 research

Post-Acute Sequelae of Covid-19: A System-wise Approach on the Effects of Long-Covid-19

Beyond the acute illness: Exploring long COVID and its impact on multiple organ systems

Diverse Immunological Factors Influencing Pathogenesis in Patients with COVID-19: A Review on Viral Dissemination, Immunotherapeutic Options to Counter Cytokine Storm and Inflammatory Responses

Clinical characteristics, multiorgan dysfunction and outcomes of patients with COVID-19: a prospective case series